The web Browser you are currently using is unsupported, and some features of this site may not work as intended. Please update to a modern browser such as Chrome, Firefox or Edge to experience all features Michigan.gov has to offer.
Asthma News
Asthma News - August 20, 2026
Current asthma research, announcements and opportunities, collected and distributed by Michigan Department of Health & Human Services (MDHHS) Asthma Program Staff. Sign up to receive weekly-ish news emails at MDHHS-Asthma@michigan.gov.
Check out the most recent MDHHS asthma social media messages and share them with your networks.
Allergy & Asthma Network Webinar: Your Asthma, Your Health: Making Informed Decisions About Vaccines ~ Sept. 3 @ 4 PM ET
What are some common questions and concerns about vaccine safety? This new patient-focused webinar can help people with asthma and their caregivers better understand the importance of staying current on vaccinations along with practical tips for discussing vaccines with your healthcare provider.Global Initiative For Asthma (GINA) 2026 Summary Guide and 2026 Severe Asthma Guide
These guides are both now available for FREE download.
Environmental Protection Agency: Asthma Awareness Resources One-Pager
This helpful one-pager includes QR codes to quickly link you to resources that can help you learn more about asthma and get it under control.
Preventable Factors in Fatal and Near-Fatal Asthma: Lessons From the British Thoracic Society (BTS) and the National Review of Asthma Deaths (NRAD)
Poor adherence to inhaled corticosteroids, overuse of short-acting β2-agonists, poor follow-up following an asthma attack, absence of asthma action plans, and failure to recognize worsening symptoms were factors. The shortcomings of standard check-ups of asthma, minimal use of controller drugs, and the inability to recognize at-risk patients were considered the key contributors to asthma death.
Low-Dose Sustained-Release Theophylline in Asthma Prevention: A Pragmatic Option for Resource-Constrained Settings
Low-dose sustained-release theophylline, used for its anti-inflammatory rather than bronchodilator effects, deserves re-evaluation as a controller option where access to standard inhaled therapies remains limited.
Predictors of asthma exacerbations in children with or without house dust mite (HDM) allergy
Exacerbation risk in asthma is associated with distinct profiles depending on sensitization status. Elevated serum soluble receptor for advanced glycation end products concentrations and increased sinonasal inflammation may characterize phenotypes not associated with HDM. In contrast, impaired lung function and poor asthma control predominate in HDM-associated asthma.